Reading Time: 2 minutes Reuters — Corona beer maker Constellation Brands will invest a further $5 billion in Canada’s top cannabis producer Canopy Growth, doubling down on one of a growing number of bets by the alcohol industry in legal pot. Constellation was among the first major alcohol producers to invest in marijuana production when it pumped about $245 […] Read more
Corona owner pours more funds into weed producer
High on farmwork
With marijuana decriminalization, what if you suspect one of your farm employees might be high at work? Or… what if they’re driving your equipment high, and you don’t even realize it?
Reading Time: 8 minutes It isn’t an easy question. How can you make sure all employees are fit for work and that they can do the job without endangering their health (or the health of others) without violating their rights or ending up in court? With recreational cannabis legalization in the parliamentary pipeline, employers in all sectors will be […] Read more
Ontario delays start date of retail cannabis sales
Reading Time: 2 minutes Toronto | Reuters — Ontario’s newly elected Tory government said Monday it will delay the start date of recreational marijuana sales in the province and will allow private retailers to sell cannabis rather than government-run stores. Ontario will allow private retailers to sell recreational marijuana starting on April 1, officials from the province’s Progressive Conservative […] Read more
Canopy Growth to buy Tokyo Smoke owner Hiku Brands
Reading Time: < 1 minute Reuters — Ontario’s Canopy Growth Corp. is buying Toyko Smoke cannabis owner Hiku Brands Co. Ltd. for $269.2 million, the latest deal in a fast-consolidating sector ahead of legal recreational marijuana sales. Smiths Falls-based Canopy Growth on Tuesday offered 0.046 of its shares, or $1.91 per share, for each Hiku share held, a premium of […] Read more
U.S. approves marijuana-derived drug for epilepsy
Reading Time: 2 minutes Reuters — The U.S. health regulator approved GW Pharmaceuticals’ epilepsy treatment on Monday, making it the first cannabis-based drug to win approval in the country and opening floodgates for more research into the medicinal properties of cannabis. The drug’s approval permits its use in patients aged two years and older with Dravet Syndrome (DS) and […] Read more
Senate approves recreational use of marijuana
Reading Time: < 1 minute Toronto | Reuters — Canada’s upper house of Parliament on Tuesday approved a revised bill to legalize recreational marijuana, setting the stage for the country to become the first Group of Seven nation to legalize cannabis. The Senate voted 52-29 in favour of the revised bill from the House of Commons, paving the way for […] Read more
Aurora to buy Ontario’s MedReleaf in biggest-ever pot deal
Reading Time: 2 minutes Reuters — Aurora Cannabis will buy rival MedReleaf Corp. for $3.2 billion in the biggest deal yet to unify major Canadian pot growers, as the country moves toward legalizing marijuana for recreational use. The deal announced Monday is the latest in a wave of mergers in the industry as marijuana producers — emboldened by pot […] Read more
Second Cup to set up cannabis lounges in West
Reading Time: 3 minutes Updated, April 13 — Canada’s No. 2 specialty coffeehouse chain has a partnership deal in place to convert some of its outlets in Western Canada to recreational cannabis shops and lounges. Second Cup on Thursday announced a “strategic alliance” with National Access Cannabis Corp. (NAC) to roll out a network of NAC-branded recreational cannabis dispensaries, […] Read more
Canada prepares for legal pot with new license class, labels
Reading Time: < 1 minute Toronto | Reuters –– Canada’s health regulator on Monday set out thresholds for a new class of cannabis cultivation and processing licenses, and outlined strict requirements for the packaging and labeling of recreational marijuana ahead of its legalization this year. The proposals were published in a document released by Health Canada, taking into account feedback […] Read more
Pot firm Aurora’s CanniMed deal gets regulatory nod
Reading Time: < 1 minute Reuters — Canada’s No. 2 marijuana producer Aurora Cannabis on Wednesday received final regulatory approval for the purchase of smaller rival CanniMed Therapeutics, which would make it the world’s most valuable weed producer. The approval of the $1.1 billion deal from the Competition Bureau follows months of tensions between the companies and comes at a […] Read more
A message from April Stewart, Country Guide's Associate Editor
